nTranexamic

Tranexamic acid has functional skin lightening activity in the treatment of melasma, as it can inhibit melanin synthesis by blocking the plasminogen/plasmin pathway, thereby preventing the interaction between melanocytes and keratinocytes. Additionally, it can promote skin exfoliation, leading to the regeneration of epidermal and dermal tissues and the reduction of pigmentary discolorations. Tranexamic has an average size of 200 nm, allowing for a more gradual and prolonged release of the encapsulated active ingredient, reducing skin irritability.

INCI Name

TRANEXAMIC ACID
nTranexamic nano brightening and anti-dark spot cosmetic ingredient

Benefits & Applications

  • Liquid
  • Skin brightening
  • Anti-inflammatory
  • Melanin inhibitor
  • Hyperpigmentation treatment
  • Skin Brightening Agent
  • Anti-inflammatory Ingredient
  • Hyperpigmentation Treatment
  • Skincare (serums, creams, masks)
  • Treatment for melasma and dark spots
  • Hyperpigmentation and uneven skin tone products
  • Asia Pacific
  • Europe
  • Latin America
  • North America
  • Reduces dark spots and hyperpigmentation
  • Evens out skin tone and brightens complexion
  • Soothes inflammation and redness
  • Improves overall skin clarity and radiance
  • ISO 9001:2015
  • Halal
  • Vegan Certified